• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment.

作者信息

Liu Wang-Da, Wang Jann-Tay, Hung Chien-Ching, Chang Shan-Chwen

机构信息

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

J Microbiol Immunol Infect. 2022 Apr;55(2):347-349. doi: 10.1016/j.jmii.2021.08.007. Epub 2021 Aug 26.

DOI:10.1016/j.jmii.2021.08.007
PMID:34462222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8388139/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/8388139/b090a7f32905/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/8388139/b090a7f32905/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/8388139/b090a7f32905/gr1_lrg.jpg

相似文献

1
Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment.一名新冠肺炎患者在接受皮质类固醇治疗后肺结核加速进展。
J Microbiol Immunol Infect. 2022 Apr;55(2):347-349. doi: 10.1016/j.jmii.2021.08.007. Epub 2021 Aug 26.
2
[A clinical study on pulmonary tuberculosis developing in association with corticosteroid treatment].[关于与皮质类固醇治疗相关的肺结核发病情况的临床研究]
Kekkaku. 1985 Aug;60(8):421-8.
3
[Immediate and late results of treatment with corticosteroid hormones of children with tuberculosis].
Probl Tuberk. 1973;51(12):46-9.
4
Risks of infection or reactivation of tuberculosis associated with chronic corticosteroid therapy.
Ann Pharmacother. 1997 Jun;31(6):775-6.
5
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis.COVID-19 治疗中的皮质类固醇：对结核病的潜在影响。
Int J Mol Sci. 2021 Apr 6;22(7):3773. doi: 10.3390/ijms22073773.
6
Corticosteroids for COVID-19: worth it or not?COVID-19 中的皮质类固醇：值得使用吗？
Mol Biol Rep. 2022 Jan;49(1):567-576. doi: 10.1007/s11033-021-06793-0. Epub 2021 Oct 13.
7
[Electrolytic pattern and secondary effects during corticosteroid therapy of pulmonary tuberculosis (clinical-statistical study by analysis of variance)].
Ann Ist Carlo Forlanini. 1968;28(4):440-56.
8
Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic.警惕 COVID-19 治疗中类固醇引起的股骨头缺血性坏死——SARS 疫情的经验与教训。
Drug Des Devel Ther. 2021 Mar 4;15:983-995. doi: 10.2147/DDDT.S298691. eCollection 2021.
9
Corticosteroid administration for viral pneumonia: COVID-19 and beyond.皮质类固醇治疗病毒性肺炎：COVID-19 及其他。
Clin Microbiol Infect. 2020 Sep;26(9):1171-1177. doi: 10.1016/j.cmi.2020.06.020. Epub 2020 Jun 27.
10
Clinical analysis of pulmonary tuberculosis in association with corticosteroid therapy.
Intern Med. 2002 Dec;41(12):1103-10. doi: 10.2169/internalmedicine.41.1103.

引用本文的文献

1
CD4 Effective Memory T Cell Markers GBP2 and LAG3 Are Risk Factors for PTB and COVID-19 Infection: A Study Integrating Single-Cell Expression Quantitative Trait Locus and Mendelian Randomization Analyses.CD4 有效记忆 T 细胞标志物 GBP2 和 LAG3 是 PTB 和 COVID-19 感染的风险因素：一项整合单细胞表达数量性状基因座和孟德尔随机化分析的研究。
Int J Mol Sci. 2024 Sep 16;25(18):9971. doi: 10.3390/ijms25189971.
2
Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis.SARS-CoV-2 再感染对卡介苗免疫具有有害影响，并促进结核分枝杆菌的传播。
Microbiol Spectr. 2022 Oct 26;10(5):e0307522. doi: 10.1128/spectrum.03075-22. Epub 2022 Oct 6.
3

本文引用的文献

1
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.印度冠状病毒疾病相关毛霉菌病的多中心流行病学研究。
Emerg Infect Dis. 2021 Sep;27(9):2349-2359. doi: 10.3201/eid2709.210934. Epub 2021 Jun 4.
2
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.新型冠状病毒病（COVID-19）大流行对侵袭性肺炎球菌病的影响以及与严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）发生肺炎球菌合并感染的风险：英格兰全国前瞻性队列研究。
Clin Infect Dis. 2021 Mar 1;72(5):e65-e75. doi: 10.1093/cid/ciaa1728.
3
Molecular and Cellular Mechanisms of and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection.
新型冠状病毒和严重急性呼吸综合征冠状病毒 2 感染的分子和细胞机制-发病机制的意外相似之处及合并感染的预期后果。
Int J Mol Sci. 2022 Feb 17;23(4):2235. doi: 10.3390/ijms23042235.
Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
肺炎链球菌尿抗原检测对降低 COVID-19 合并感染患者死亡率的有效性：一项临床研究。
Medicina (Kaunas). 2020 Oct 29;56(11):572. doi: 10.3390/medicina56110572.
4
A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis.一项关于 22 例 COVID-19 合并活动性/治疗性结核病患者的回顾性队列研究。
Eur Respir J. 2020 Nov 19;56(5). doi: 10.1183/13993003.03408-2020. Print 2020 Nov.
5
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?COVID-19 患者的合并感染：是否需要使用非抗 SARS-CoV-2 药物进行联合治疗？
J Microbiol Immunol Infect. 2020 Aug;53(4):505-512. doi: 10.1016/j.jmii.2020.05.013. Epub 2020 May 23.
6
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染：系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
7
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.活动性肺结核、后遗症与 COVID-19 合并感染：49 例首批队列。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
8
Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function.糖皮质激素增强的胞葬作用通过降低肺泡巨噬细胞杀菌功能抑制小鼠肺部肺炎球菌清除。
J Immunol. 2015 Jul 1;195(1):174-84. doi: 10.4049/jimmunol.1402217. Epub 2015 May 18.
9
Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update.长期使用吸入性皮质类固醇治疗慢性阻塞性肺疾病与肺炎风险：批判性回顾与更新。
Curr Opin Pulm Med. 2010 Mar;16(2):118-22. doi: 10.1097/MCP.0b013e328334c085.